Patent details

Basic Information

Publication number:

EP1343523

PCT Application Number:

PCT/EP/2001/015132

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019957059

PCT Publication Number:

WO/2002/049665

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF ACTIVATED COAGULATION FACTOR VII FOR TREATING THROMBOLYTIC THERAPY-INDUCED MAJOR BLEEDINGS

French Title of Invention:

UTILISATION DU FACTEUR VII DE COAGULATION ACTIVE POUR TRAITER DES HEMORRAGIES IMPORTANTES CAUSEES PAR UNE THERAPIE THROMBOLYTIQUE

German Title of Invention:

VERWENDUNG VON AKTIVIERTEM GERINNUNGSFAKTOR VII ZUR BEHANDLUNG VON DURCH THROMBOLYTISCHE THERAPIE-INDUZIERTEN WICHTIGEN BLUTUNGEN

SPC Number:

Dates

Filing date:

20/12/2001

Grant date:

14/02/2007

EP Publication Date:

14/02/2007

PCT Publication Date:

27/06/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/09/2003

EP B1 Publication Date:

14/02/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/12/2010

Expiration date:

20/12/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/12/2001

 

 

Name:

Boehringer Ingelheim Pharma GmbH & Co. KG

Address:

-, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:

HEUSEL Gerhard

Address:

Germany (DE)

2

Name:

WIENEN Wolfgang

Address:

Germany (DE)

3

Name:

SKAMIRA Cord

Address:

Germany (DE)

4

Name:

STASSEN Jean, Marie

Address:

Belgium (BE)

Priority

Priority Number:

00128252

Priority Date:

21/12/2000

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 38/48;

Filing date	Document type	Number of pages